Evidence map›Paper›PMID 40016516›Full record

ArticleLab animal2025

Use of HSA

Marc Carrascosa-Sàez, Anna Colom-Rodrigo, Irene González-Martínez, Raquel Pérez-Gómez, Andrea García-Rey, Diego Piqueras-Losilla, Ana Ballestar, Beatriz Llamusí, Estefanía Cerro-Herreros, Ruben Artero

Abstract read
In one paragraph

Article in Lab animal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Oleic Acid Levels in HSAInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. HSAInternational journal of molecular sciences · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marc Carrascosa-Sàez *ARTHEx Biotech, Paterna, Spain.ORCID 0000-0002-5477-8323
Anna Colom-Rodrigo *ARTHEx Biotech, Paterna, Spain.ORCID 0000-0003-2902-8237
Irene González-Martínez *CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Raquel Pérez-GómezHuman Translational Genomics Group, University Institute of Biotechnology and Biomedicine, Universidad de Valencia, Burjassot, Spain.
Andrea García-ReyHuman Translational Genomics Group, University Institute of Biotechnology and Biomedicine, Universidad de Valencia, Burjassot, Spain.
Diego Piqueras-LosillaARTHEx Biotech, Paterna, Spain.
Ana BallestarHuman Translational Genomics Group, University Institute of Biotechnology and Biomedicine, Universidad de Valencia, Burjassot, Spain.
Beatriz LlamusíARTHEx Biotech, Paterna, Spain.
Estefanía Cerro-HerrerosARTHEx Biotech, Paterna, Spain. estefania.cerro@uv.es.ORCID 0000-0003-3247-5900
Ruben ArteroCIBER de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0003-1596-047X

Funding

EC | European Regional Development Fund (Europski Fond za Regionalni Razvoj) OP ERDF of Comunitat Valenciana 2014-2020Generalitat Valenciana (Regional Government of Valencia) FDEGENT/2020/001Generalitat Valenciana (Regional Government of Valencia) PROMETEO/2020/081'la Caixa' Foundation (Caixa Foundation) HR17-00268Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) DTS19/00128
6 · The paper itself

Abstract

HSA

Indexed as

Disease Models, AnimalMyotonic DystrophyAnimalsFemaleMaleMiceMuscle, SkeletalPhenotypeSex Factors

Identifiers

PMID40016516
PMCPMC11957995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.